Adjuvant Chemotherapy of Stage I Non-small Cell Lung Cancer in North America

This publication has 16 references indexed in Scilit:

• Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients
  Journal of Clinical Oncology, 2006
• Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633
  Journal of Clinical Oncology, 2006
• Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2005
• ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association
  Journal of Clinical Oncology, 2005
• Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633
  Journal of Clinical Oncology, 2004
• Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
  European Journal of Cardio-Thoracic Surgery, 2004
• Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2004
• Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2003
• A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2000
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995